Advertisement
Screener

Lite Strategy, Inc. (LITS) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period

2.2 / 5 stars · 45/104 Roast Me

Lite Strategy, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period

Lite Strategy, Inc. (LITS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 8.83 thousand shares for the 12-month period ending 2014-06-30, per its 10-K filed 2014-09-09.

Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2014-09-09

  • Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2014-06-30 was 8.00K shares.
  • Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2014 was 8.83K shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month
2014-06-308.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-09
8.83K shares
10-K · filed 2014-09-09
2014-03-31833.00 shares
10-Q · filed 2014-05-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
Dogwood Therapeutics, Inc. (DWTX)United States$0.049B
Elicio Therapeutics, Inc. (ELTX)United States$0.049B
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
Grace Therapeutics, Inc. (GRCE)$0.046B-1.83
Xilio Therapeutics, Inc. (XLO)United States$0.052B
PDS Biotechnology Corp (PDSB)United States$0.045B
SCYNEXIS INC (SCYX)United States$0.045B
Serina Therapeutics, Inc. (SER)United States$0.054B-2.35
Clene Inc. (CLNN)United States$0.054B-1.99
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38